Brief: Tetra Bio-Pharma Signs License Agreement With Thorne For A Prebiotic Dietary Supplement
22/02/2022 12:14
Feb 22 (Reuters) - Tetra Bio Pharma Inc TBP.TO :
* TETRA BIO-PHARMA SIGNS LICENSE AGREEMENT WITH THORNE FOR A
PREBIOTIC DIETARY SUPPLEMENT
* TETRA BIO PHARMA INC - AGREEMENT WILL INCLUDE ROYALTY ON
SALES
AND MILESTONE PAYMENTS
Source text for Eikon: ID:nCNW6QVYYa
Further company coverage: TBP.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Thorne HealthTech
See all newsBrief: L Catterton And Thorne Healthtech, Inc. Announce Expiration Of Tender Offer
Brief: L Catterton And Thorne Healthtech Announce Expiration Of Tender Offer
Brief: Thorne Healthtech Received Notice Of Delisting From Nasdaq
Brief: Kirin Holdings To Sell All Of 29.1% Stake It Owns In Thorne Healthtech For About 23 Billion Yen - Nikkei
U.S. RESEARCH ROUNDUP- Celsius Holdings, RPT Realty, Thorne Healthtech